Table 1.
Antigens
| Antigen (designation) | Concn (μg/ml) | Source(s) |
|---|---|---|
| M. bovis purified protein derivative (PPDb) | 0.1, 1.0, 10 | CSL,a Lelystad,b Perugia,c Weybridge,d AsureQualitye |
| M. avium purified protein derivative (PPDa) | 0.1, 1.0, 10 | CSL, Lelystad, Perugia, Weybridge, AsureQuality |
| Early secretory antigenic target-6:culture Filtrate protein 10 (E:C) | 1.0, 5.0 | Iowa State University,f Lionex,g AHVLAh |
| Outer membrane protein A of M. tuberculosis (OmpATB) (24) | 5.0 | Proteixi |
| TB10.4 | 5.0 | Proteix |
| TB27.4 | 5.0 | Proteix |
| Mobility protein of M. bovis 83 (MPB83) | 1.0, 5.0, 10.0 | NADC,j Lionex |
a
Prionics Ag, Schlieren, Switzerland.
b
Lelystad Biologicals, Lelystad, Netherlands.
c
Istituto Zooprofilatico, Perugia, Spain.
d
Tuberculin Production Unit, VLA, Weybridge, United Kingdom.
e
AsureQuality, Auckland, New Zealand.
f
Chris Minion, Veterinary Microbiology and Preventive Medicine, Iowa State University Ames, Iowa.
g
Lionex Diagnostics and Therapeutics GmbH, Braunschweig, Germany.
h
Animal Health and Veterinary Laboratory Agencies, Weybridge, United Kingdom.
i
Proteix Biotechnologies, Prague, Czech Republic.
j
John Bannantine, National Animal Disease Center, Ames, IA.